Evidence map›Paper›PMID 20181604›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2010

Homer 1a gates the induction mechanism for endocannabinoid-mediated synaptic plasticity.

Alan M Roloff, Garret R Anderson, Kirill A Martemyanov, Stanley A Thayer

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The Endocannabinoid Signaling System in the CNS: A Primer.International review of neurobiology · 2015
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Alan M RoloffDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA.
Garret R Anderson
Kirill A Martemyanov
Stanley A Thayer
University of Minnesota Medical Center · USTwin Cities Orthopedics · USUniversity of Minnesota · US

Funding

Subcellular Targeting/Packaging of Opioids/ReceptorsP50DA011806 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LOH, HORACE · 1998 to 2012
$14.0M
Training in PharmacoNeuroImmune Substance Abuse ResearchT32DA007097 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOLITOR, THOMAS WILLIAM · 1985 to 2021
$13.1M
HIV NEUROTOXICITY--MECHANISM &MODULATION BY CANABINOIDSR01DA007304 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI THAYER, STANLEY A · 1992 to 2024
$5.0M
HIV Neurotoxicity-Mechanism &Modulation by CannabinoidsR37DA007304 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI THAYER, STANLEY A · 2004 to 2013
$3.1M
RESEARCH TRAINING IN DRUG ABUSE BEHAVIORT32DA007304 · NIDA · UNIVERSITY OF KENTUCKY · PI RUSH, CRAIG R · 1998 to 2012
$3.1M
Molecular Basis of RGS Protein Function in the StriatumR01DA021743 · NIDA · UNIVERSITY OF MINNESOTA · PI MARTEMYANOV, KIRILL A. · 2007 to 2011
$1.3M
Molecular Basis of RGS Protein Function in the StriatumK02DA026405 · NIDA · UNIVERSITY OF MINNESOTA · PI MARTEMYANOV, KIRILL A. · 2009 to 2019
$1.2M
Cannabinoid Modulation of Recovery from HIV-Associated Synaptic ToxicityR21DA024428 · NIDA · UNIVERSITY OF MINNESOTA · PI THAYER, STANLEY A · 2007 to 2008
$407k
Alterations in RGS9 Degradation Mechanisms Conferred by OpioidsF31DA024944 · NIDA · UNIVERSITY OF MINNESOTA · PI ANDERSON, GARRET R. · 2009 to 2010
$47k
NIDA NIH HHS DA021743NIDA NIH HHS DA024944NIDA NIH HHS DA026405NIDA NIH HHS DA07097NIDA NIH HHS DA07304NIDA NIH HHS DA11806NIDA NIH HHS DA24428NIDA NIH HHS F31 DA024944NIDA NIH HHS K02 DA026405NIDA NIH HHS P50 DA011806NIDA NIH HHS R01 DA007304NIDA NIH HHS R01 DA021743NIDA NIH HHS R21 DA024428NIDA NIH HHS R37 DA007304NIDA NIH HHS T32 DA007097NIDA NIH HHS T32 DA007304
6 · The paper itself

Abstract

At hippocampal excitatory synapses, endocannabinoids (eCBs) mediate two forms of retrograde synaptic inhibition that are induced by postsynaptic depolarization or activation of metabotropic glutamate receptors (mGluRs). The homer family of molecular scaffolds provides spatial organization to regulate postsynaptic signaling cascades, including those activated by mGluRs. Expression of the homer 1a (H1a) immediate-early gene produces a short homer protein that lacks the domain required for homer oligomerization, enabling it to uncouple homer assemblies. Here, we report that H1a differentially modulates two forms of eCB-mediated synaptic plasticity, depolarization-induced suppression of excitation (DSE) and metabotropic suppression of excitation (MSE). EPSCs were recorded from cultured hippocampal neurons and DSE evoked by a 15 s depolarization to 0 mV and MSE evoked by a type I mGluR agonist. Expression of H1a enhanced DSE and inhibited MSE at the same synapse. Many physiologically important stimuli initiate H1a expression including brain-derived neurotrophic factor (BDNF). Treating hippocampal cultures with BDNF increased transcription of H1a and uncoupled homer 1c-GFP (green fluorescent protein) clusters. BDNF treatment blocked MSE and enhanced DSE. Thus, physiological changes in H1a expression gate the induction pathway for eCB-mediated synaptic plasticity by uncoupling mGluR from eCB production.

Indexed as

EndocannabinoidsAction PotentialsAnimalsBrain-Derived Neurotrophic FactorCannabinoid Receptor ModulatorsCarrier ProteinsCells, CulturedExcitatory Amino Acid AgonistsExcitatory Postsynaptic PotentialsGreen Fluorescent ProteinsHippocampusHomer Scaffolding ProteinsIon Channel GatingMembrane PotentialsNeural InhibitionNeural PathwaysBrain-Derived Neurotrophic FactorCannabinoid Receptor ModulatorsCarrier ProteinsEndocannabinoidsExcitatory Amino Acid AgonistsGreen Fluorescent ProteinsHomer Scaffolding Proteinsmetabotropic glutamate receptor type 1Receptors, Metabotropic GlutamateRecombinant Fusion Proteins

Identifiers

PMID20181604
PMCPMC2843151
OpenAlexW2080615842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.